A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS

Objective:To assess the efficacy of an innovative smoking cessation intervention targeted to a multiethnic, economically disadvantaged HIV-positive population. Design:A two-group randomized clinical trial compared a smoking cessation intervention delivered by cellular telephone with usual care approach. Methods:Current smokers from a large, inner city HIV/AIDS care center were recruited and randomized to receive either usual care or a cellular telephone intervention. The usual care group received brief physician advice to quit smoking, targeted self-help written materials and nicotine replacement therapy. The cellular telephone intervention received eight counseling sessions delivered via cellular telephone in addition to the usual care components. Smoking-related outcomes were assessed at a 3-month follow-up. Results:The trial had 95 participants and 77 (81.0%) completed the 3-month follow-up assessment. Analyses indicated biochemically verified point prevalence smoking abstinence rates of 10.3% for the usual care group and 36.8% for the cellular telephone group; participants who received the cellular telephone intervention were 3.6 times (95% confidence interval, 1.3-9.9) more likely to quit smoking compared with participants who received usual care (P = 0.0059). Conclusions:These results suggest that individuals living with HIV/AIDS are receptive to, and can be helped by, smoking cessation treatment. In addition, smoking cessation treatment tailored to the special needs of individuals living with HIV/AIDS, such as counseling delivered by cellular telephone, can significantly increase smoking abstinence rates over that achieved by usual care.

[1]  M. Kolczak,et al.  Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. , 2000, The New England journal of medicine.

[2]  T. Powles,et al.  HIV-related lung cancer - a growing concern? , 2003, International journal of STD & AIDS.

[3]  R. Rosenfeld,et al.  Upper aerodigestive tract squamous cell carcinoma. The human immunodeficiency virus connection. , 1996, Archives of otolaryngology--head & neck surgery.

[4]  A. Malarcher,et al.  Cigarette Smoking Among Adults in the United States , 2008 .

[5]  B. Bozkurt.  Cardiovascular toxicity with highly active antiretroviral therapy , 2007, Cardiovascular Toxicology.

[6]  S. Marmor,et al.  Lung cancer in patients with HIV infection: is it AIDS‐related? , 2004, HIV medicine.

[7]  D E Kanouse,et al.  Changes in health-promoting behavior following diagnosis with HIV: prevalence and correlates in a national probability sample. , 2001, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[8]  P. Sax,et al.  Tolerability and Safety of HIV Protease Inhibitors in Adults , 2004, Journal of acquired immune deficiency syndromes.

[9]  D R Taves,et al.  Minimization: A new method of assigning patients to treatment and control groups , 1974, Clinical pharmacology and therapeutics.

[10]  Edward Mamary,et al.  Cigarette smoking and the desire to quit among individuals living with HIV. , 2002, AIDS patient care and STDs.

[11]  E. Gilpin,et al.  Duration of smoking abstinence and success in quitting. , 1997, Journal of the National Cancer Institute.

[12]  H. Colt,et al.  AIDS-related spontaneous pneumothorax. Risk factors and treatment. , 1995, Chest.

[13]  D. Vidrine,et al.  Smoking behavior in a low-income multiethnic HIV/AIDS population. , 2004, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[14]  J. Neuhaus,et al.  Effect of receptive oral sex and smoking on the incidence of hairy leukoplakia in HIV-positive gay men. , 1999, Journal of acquired immune deficiency syndromes.

[15]  L. Kalish,et al.  Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. , 1999, Journal of the National Cancer Institute.

[16]  Karl Fagerstrom,et al.  Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire , 1989, Journal of Behavioral Medicine.

[17]  Lisa B. Gelling,et al.  Epidemiologic Relation between HIV and Invasive Pneumococcal Disease in San Francisco County, California , 2000, Annals of Internal Medicine.

[18]  D. Vidrine,et al.  Increasing access to smoking cessation treatment in a low-income, HIV-positive population: the feasibility of using cellular telephones. , 2004, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[19]  M. Goolsby,et al.  Treating Tobacco Use and Dependence , 2008, Pediatrics.

[20]  J. Neidig,et al.  The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers. , 2000, The Journal of the Association of Nurses in AIDS Care : JANAC.

[21]  T. Powles,et al.  Head and neck cancer in patients with human immunodeficiency virus-1 infection: incidence, outcome and association with Epstein-Barr virus , 2004, The Journal of Laryngology & Otology.

[22]  Cigarette smoking among adults--United States, 2003. , 2005, MMWR. Morbidity and mortality weekly report.

[23]  C. Spielberger,et al.  STAI manual for the State-trait anxiety inventory ("self-evaluation questionnaire") , 1970 .

[24]  Gary D Slade,et al.  Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults. , 2005, Community dentistry and oral epidemiology.

[25]  Patricia Dolan Mullen,et al.  Treating tobacco use and dependence: clinical practice guideline , 2000 .

[26]  L. Radloff.  The CES-D Scale , 1977 .

[27]  R. Swoboda,et al.  Th1/Th2 cytokine profiles in saliva of HIV-positive smokers with oropharyngeal candidiasis. , 2002, Oral microbiology and immunology.

[28]  A. Schuchat,et al.  Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. , 1999, The Journal of infectious diseases.

[29]  J. Butler.  Cigarette smoking and invasive pneumococcal disease , 2000 .

[30]  D. Serraino,et al.  Lung carcinoma in 36 patients with human immunodeficiency virus infection , 2000, Cancer.

[31]  C. Sherbourne,et al.  The MOS social support survey. , 1991, Social science & medicine.

[32]  J. Palefsky,et al.  Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIV-negative homosexual men. , 1994, Journal of acquired immune deficiency syndromes.

[33]  K. Tashima,et al.  Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.